| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |